Literature DB >> 18579843

A model for expanded public health reporting in the context of HIPAA.

Soumitra Sengupta1, Neil S Calman, George Hripcsak.   

Abstract

The advent of electronic medical records and health information exchange raise the possibility of expanding public health reporting to detect a broad range of clinical conditions and of monitoring the health of the public on a broad scale. Expanding public health reporting may require patient anonymity, matching records, re-identifying cases, and recording patient characteristics for localization. The privacy regulations under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) provide several mechanisms for public health surveillance, including using laws and regulations, public health activities, de-identification, research waivers, and limited data sets, and in addition, surveillance may be distributed with aggregate reporting. The appropriateness of these approaches varies with the definition of what data may be included, the requirements of the minimum necessary standard, the accounting of disclosures, and the feasibility of the approach.

Entities:  

Mesh:

Year:  2008        PMID: 18579843      PMCID: PMC2528028          DOI: 10.1197/jamia.M2207

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  16 in total

Review 1.  Weaving technology and policy together to maintain confidentiality.

Authors:  L Sweeney
Journal:  J Law Med Ethics       Date:  1997 Summer-Fall       Impact factor: 1.718

2.  New York City and state legal authorities related to syndromic surveillance.

Authors:  Wilfredo Lopez
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

3.  BioSense: implementation of a National Early Event Detection and Situational Awareness System.

Authors:  Colleen A Bradley; H Rolka; D Walker; J Loonsk
Journal:  MMWR Suppl       Date:  2005-08-26

4.  Facing the diabetes epidemic--mandatory reporting of glycosylated hemoglobin values in New York City.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

5.  Benefits and barriers to electronic laboratory results reporting for notifiable diseases: the New York City Department of Health and Mental Hygiene experience.

Authors:  Trang Quyen Nguyen; Lorna Thorpe; Hadi A Makki; Farzad Mostashari
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

6.  Statutory basis for public health reporting beyond specific diseases.

Authors:  Claire V Broome; Heather H Horton; Deborah Tress; Salvatore J Lucido; Denise Koo
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

7.  Syndromic surveillance using minimum transfer of identifiable data: the example of the National Bioterrorism Syndromic Surveillance Demonstration Program.

Authors:  Richard Platt; Carmella Bocchino; Blake Caldwell; Robert Harmon; Ken Kleinman; Ross Lazarus; Andrew F Nelson; James D Nordin; Debra P Ritzwoller
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

8.  Guaranteeing anonymity when sharing medical data, the Datafly System.

Authors:  L Sweeney
Journal:  Proc AMIA Annu Fall Symp       Date:  1997

9.  HIPAA privacy rule and public health. Guidance from CDC and the U.S. Department of Health and Human Services.

Authors: 
Journal:  MMWR Suppl       Date:  2003-05-02

10.  Implementing syndromic surveillance: a practical guide informed by the early experience.

Authors:  Kenneth D Mandl; J Marc Overhage; Michael M Wagner; William B Lober; Paola Sebastiani; Farzad Mostashari; Julie A Pavlin; Per H Gesteland; Tracee Treadwell; Eileen Koski; Lori Hutwagner; David L Buckeridge; Raymond D Aller; Shaun Grannis
Journal:  J Am Med Inform Assoc       Date:  2003-11-21       Impact factor: 4.497

View more
  7 in total

1.  Using health information exchange to improve public health.

Authors:  Jason S Shapiro; Farzad Mostashari; George Hripcsak; Nicholas Soulakis; Gilad Kuperman
Journal:  Am J Public Health       Date:  2011-02-17       Impact factor: 9.308

2.  The role of law in supporting secondary uses of electronic health information.

Authors:  Tara Ramanathan; Cason Schmit; Akshara Menon; Chanelle Fox
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

3.  A secure protocol for protecting the identity of providers when disclosing data for disease surveillance.

Authors:  Khaled El Emam; Jun Hu; Jay Mercer; Liam Peyton; Murat Kantarcioglu; Bradley Malin; David Buckeridge; Saeed Samet; Craig Earle
Journal:  J Am Med Inform Assoc       Date:  2011-05-01       Impact factor: 4.497

4.  Physician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak.

Authors:  Khaled El Emam; Jay Mercer; Katherine Moreau; Inese Grava-Gubins; David Buckeridge; Elizabeth Jonker
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

5.  A Protocol for the secure linking of registries for HPV surveillance.

Authors:  Khaled El Emam; Saeed Samet; Jun Hu; Liam Peyton; Craig Earle; Gayatri C Jayaraman; Tom Wong; Murat Kantarcioglu; Fida Dankar; Aleksander Essex
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

6.  Security controls in an integrated Biobank to protect privacy in data sharing: rationale and study design.

Authors:  Takako Takai-Igarashi; Kengo Kinoshita; Masao Nagasaki; Soichi Ogishima; Naoki Nakamura; Sachiko Nagase; Satoshi Nagaie; Tomo Saito; Fuji Nagami; Naoko Minegishi; Yoichi Suzuki; Kichiya Suzuki; Hiroaki Hashizume; Shinichi Kuriyama; Atsushi Hozawa; Nobuo Yaegashi; Shigeo Kure; Gen Tamiya; Yoshio Kawaguchi; Hiroshi Tanaka; Masayuki Yamamoto
Journal:  BMC Med Inform Decis Mak       Date:  2017-07-06       Impact factor: 2.796

Review 7.  Use and Understanding of Anonymization and De-Identification in the Biomedical Literature: Scoping Review.

Authors:  Raphaël Chevrier; Vasiliki Foufi; Christophe Gaudet-Blavignac; Arnaud Robert; Christian Lovis
Journal:  J Med Internet Res       Date:  2019-05-31       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.